Work

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study

Year: 2014

Type: article

Study design: Observational Study

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2014-205216

Authors: Seoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, Michael Doherty, Allison B Goldfine, Daniel H Solomon

Institutions: Brigham and Women's Hospital, Harvard University, Joslin Diabetes Center

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: G1048483529, G1541234594, Modifiable Disparities in Treatment for Rheumatoid Arthritis, Patient Centered Outcomes Research in Rheumatology, G3144655465, G5981859630, G629174108, G810844044, G846364778, Metabolic Syndrome, Inflammation and Vascular Remodeling, Durability and Mechanisms of Bariatric Surgery vs Medical Therapy in Obese T2D

OpenAlex ID: W2030784115

FWCI: 4.547

Cites: 63

Cited by: 115

Related to: 10